GE HealthCare Technologies (GEHC) Cash from Operations Growth (1y) (2023 - 2026)

GE HealthCare Technologies (GEHC) Cash from Operations Growth (1y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Ops. Growth (1y) (Qtr)
1	Abbott Laboratories	199.63 Bn	194.02 Bn	7.27 Bn	21.54%
2	Stryker	127.42 Bn	123.95 Bn	4.50 Bn	13.50%
3	Medtronic	118.97 Bn	109.75 Bn	6.41 Bn	1.78%
4	Boston Scientific	73.39 Bn	72.85 Bn	3.85 Bn	14.62%
5	Edwards Lifesciences	51.97 Bn	47.72 Bn	1.35 Bn	124.64%
6	Dexcom	34.32 Bn	32.37 Bn	830.00 Mn	-11.16%
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	78.72%
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	-0.23%
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn	-12.60%
10	Zimmer Biomet Holdings	19.18 Bn	18.77 Bn	1.54 Bn	18.40%

Download Data